CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,936 | +328.3% | 4,017 | +212.6% | 0.00% | – |
| Q2 2023 | $452 | – | 1,285 | -6.7% | 0.00% | – |
| Q1 2023 | $0 | -100.0% | 1,377 | -1.2% | 0.00% | – |
| Q4 2022 | $1 | -99.9% | 1,394 | -32.9% | 0.00% | – |
| Q3 2022 | $1,000 | -50.0% | 2,076 | +75.3% | 0.00% | – |
| Q2 2022 | $2,000 | 0.0% | 1,184 | -62.7% | 0.00% | – |
| Q1 2022 | $2,000 | -85.7% | 3,175 | +15.5% | 0.00% | – |
| Q1 2021 | $14,000 | 0.0% | 2,748 | +22.8% | 0.00% | – |
| Q4 2020 | $14,000 | -82.3% | 2,238 | -87.8% | 0.00% | -100.0% |
| Q3 2020 | $79,000 | +19.7% | 18,326 | +61.9% | 0.00% | -66.7% |
| Q2 2020 | $66,000 | +725.0% | 11,322 | +585.8% | 0.00% | – |
| Q1 2020 | $8,000 | -55.6% | 1,651 | -38.6% | 0.00% | -100.0% |
| Q4 2019 | $18,000 | – | 2,688 | +3062.4% | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 85 | -97.9% | 0.00% | -100.0% |
| Q2 2019 | $29,000 | +2800.0% | 4,037 | +2288.8% | 0.00% | – |
| Q1 2019 | $1,000 | -90.0% | 169 | -81.8% | 0.00% | -100.0% |
| Q3 2018 | $10,000 | +150.0% | 931 | +148.9% | 0.00% | – |
| Q2 2018 | $4,000 | – | 374 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 471,448 | $5,502,000 | 3.04% |
| ACUTA CAPITAL PARTNERS, LLC | 830,000 | $9,686,000 | 1.72% |
| NEXTHERA CAPITAL LP | 786,865 | $9,183,000 | 1.42% |
| Ghost Tree Capital, LLC | 355,000 | $4,143,000 | 1.22% |
| Point72 Europe (London) LLP | 83,500 | $974,000 | 0.52% |
| Virtus ETF Advisers LLC | 31,061 | $362,000 | 0.32% |
| Eventide Asset Management | 246,000 | $2,871,000 | 0.12% |
| Kalos Management, Inc. | 8,500 | $244,000 | 0.11% |
| MARSHALL WACE, LLP | 550,352 | $6,423,000 | 0.10% |
| GSA CAPITAL PARTNERS LLP | 157,145 | $1,834,000 | 0.09% |